Subarachnoid hemorrhage (SAH) associated with a rupturedcerebral aneurysm remains a source of significant morbidityand mortality, not only from the initial hemorrhage butalso from the delayed complications, such as cerebral vasospasmoften severe enough to induce irreversible changes in cerebralperfusion. Several drugs have been developed that have thepotential to limit cerebral vasospasm and delayed ischemicneurologic deficit, thus improving outcome for patients.
|Number of pages||3|
|Publication status||Published - 2012|
All Science Journal Classification (ASJC) codes
- Clinical Neurology